دورية أكاديمية
Knowledge domains and emerging trends in radiotherapy in oesophageal cancer from 2004 to 2023: a bibliometric analysis and visualization study.
| العنوان: | Knowledge domains and emerging trends in radiotherapy in oesophageal cancer from 2004 to 2023: a bibliometric analysis and visualization study. |
|---|---|
| المؤلفون: | Feng Y; Department of Radiotherapy, Shuguang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine, 528 Zhangheng Road, Pudong New Area, Shanghai 200135, China., Lv M; Department of Radiotherapy, Shuguang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine, 528 Zhangheng Road, Pudong New Area, Shanghai 200135, China., Zeng S; Department of Radiotherapy, Shuguang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine, 528 Zhangheng Road, Pudong New Area, Shanghai 200135, China., Zeng H; Department of Radiotherapy, Shuguang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine, 528 Zhangheng Road, Pudong New Area, Shanghai 200135, China., Yu J; Department of Radiotherapy, Shuguang Hospital Affiliated to Shanghai University of Chinese Traditional Medicine, 528 Zhangheng Road, Pudong New Area, Shanghai 200135, China. |
| المصدر: | Journal of radiation research [J Radiat Res] 2024 Jul 22; Vol. 65 (4), pp. 433-449. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0376611 Publication Model: Print Cited Medium: Internet ISSN: 1349-9157 (Electronic) Linking ISSN: 04493060 NLM ISO Abbreviation: J Radiat Res Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: July 2012- : Oxford : Oxford University Press Original Publication: Tokyo : Japan Radiation Research Society |
| مواضيع طبية MeSH: | Bibliometrics* , Esophageal Neoplasms*/radiotherapy, Humans ; Radiotherapy |
| مستخلص: | Esophageal cancer (EC) is a malignant tumour with high morbidity and mortality rates. Recent studies have shown that much progress has been made in the research of radiotherapy in EC. This study aims to provide a comprehensive overview of the knowledge structure and research hotspots of radiotherapy in EC through bibliometrics. Publications related to radiotherapy in EC from 2014 to 2023 were searched on the web of science core collection database. VOSviewers, CiteSpace and R package 'bibliometrix' were used to conduct this bibliometric analysis. In total, 4258 articles from 76 countries led by China and the USA were included. The Chinese Academy of Medical Sciences-Peking Union Medical College has the highest number of publications. International Journal of Radiation Oncology Biology Physics is the most popular journal and also the most co-cited journal in this field. These publications come from 21 972 authors among which Liao Zhongxing had published the most papers and Cooper JS was co-cited most often. Neoadjuvant chemoradiotherapy and strategies based on it are the main topics in this research field. 'IMRT' and 'immunotherapy' are the primary keywords of emerging research hotspots. This is a bibliometric study that comprehensively summarizes the research trends and developments of radiotherapy in EC. This information identifies recent research frontiers and hot directions, which will provide a reference for scholars studying radiotherapy in EC. (© The Author(s) 2024. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology.) |
| References: | Radiother Oncol. 2005 Dec;77(3):247-53. (PMID: 16298001) Eur J Cancer. 2021 Feb;144:232-241. (PMID: 33373868) Front Oncol. 2022 Nov 02;12:1034656. (PMID: 36408184) Int J Infect Dis. 2020 Jul;96:696-709. (PMID: 32434084) Biomed Res Int. 2019 Apr 03;2019:1495130. (PMID: 31073519) Radiother Oncol. 2017 Jun;123(3):376-381. (PMID: 28455153) Front Immunol. 2022 Dec 15;13:1096806. (PMID: 36591239) Jpn J Radiol. 2012 Jan;30(1):18-24. (PMID: 22160648) N Engl J Med. 2021 Apr 1;384(13):1191-1203. (PMID: 33789008) Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1580-6. (PMID: 22284687) Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e345-51. (PMID: 22417808) Front Pharmacol. 2020 Feb 07;11:37. (PMID: 32116713) Radiother Oncol. 2001 Nov;61(2):157-63. (PMID: 11690681) AMIA Annu Symp Proc. 2005;:724-8. (PMID: 16779135) J Surg Oncol. 2005 Jun 15;90(4):209-19. (PMID: 15906363) PLoS One. 2016 Apr 21;11(4):e0151988. (PMID: 27100968) Cancers (Basel). 2014 Dec 05;6(4):2356-68. (PMID: 25489937) Curr Oncol. 2021 Nov 08;28(6):4504-4520. (PMID: 34898576) Gastroenterology. 2022 Sep;163(3):649-658.e2. (PMID: 35671803) Lancet Oncol. 2017 May;18(5):631-639. (PMID: 28314688) Ann Surg. 2010 Nov;252(5):744-9. (PMID: 21037429) World J Gastroenterol. 2014 Oct 14;20(38):13973-80. (PMID: 25320535) Front Pharmacol. 2020 Mar 13;11:294. (PMID: 32231572) CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338) Am J Gastroenterol. 2021 May 1;116(5):1072-1076. (PMID: 33929382) Scientometrics. 2010 Aug;84(2):523-538. (PMID: 20585380) J Radiat Res. 2018 Sep 1;59(5):604-615. (PMID: 30085197) Am J Gastroenterol. 2017 Aug;112(8):1247-1255. (PMID: 28585555) Br J Radiol. 2004 Jul;77(919):568-72. (PMID: 15238403) Front Pharmacol. 2020 Jun 05;11:842. (PMID: 32581801) PeerJ. 2018 Aug 15;6:e5477. (PMID: 30128213) Expert Rev Anticancer Ther. 2017 Jul;17(7):635-646. (PMID: 28503964) J Clin Oncol. 2020 May 10;38(14):1569-1579. (PMID: 32160096) JAMA. 1999 May 5;281(17):1623-7. (PMID: 10235156) Strahlenther Onkol. 2013 Apr;189(4):293-300. (PMID: 23443611) BMC Surg. 2008 Nov 26;8:21. (PMID: 19036143) Lancet Oncol. 2015 Sep;16(9):1090-1098. (PMID: 26254683) J Appl Clin Med Phys. 2014 May 08;15(3):93–101. (PMID: 24892336) South Med J. 2021 Mar;114(3):161-168. (PMID: 33655310) Cancers (Basel). 2024 Feb 03;16(3):. (PMID: 38339409) J Clin Oncol. 2003 Jul 15;21(14):2697-702. (PMID: 12860946) Lancet Oncol. 2007 Mar;8(3):226-34. (PMID: 17329193) J Orthop Surg Res. 2022 Mar 28;17(1):194. (PMID: 35346273) Clin Exp Med. 2021 May;21(2):181-194. (PMID: 32266495) N Engl J Med. 2012 May 31;366(22):2074-84. (PMID: 22646630) J Clin Oncol. 2002 Mar 1;20(5):1167-74. (PMID: 11870157) |
| معلومات مُعتمدة: | 202 340 160 Scientific Research Project of Shanghai Municipal Health Commission; 23KFL105 Science and Technology Development Project of Shanghai University of Traditional Chinese Medicine; SGZXY-202201 Integrated Chinese and Western Medicine Project of Shuguang Hospital affiliated with Shanghai University of Traditional Chinese Medicine |
| فهرسة مساهمة: | Keywords: CiteSpace; VOSviewers; bibliometrics; esophageal cancer; radiotherapy |
| تواريخ الأحداث: | Date Created: 20240606 Date Completed: 20240722 Latest Revision: 20240724 |
| رمز التحديث: | 20240725 |
| مُعرف محوري في PubMed: | PMC11262863 |
| DOI: | 10.1093/jrr/rrae040 |
| PMID: | 38842165 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1349-9157 |
|---|---|
| DOI: | 10.1093/jrr/rrae040 |